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Abstract
Background Transcatheter aortic valve replacement (TAVR)
is a novel technique developed in the last decade to treat
severe aortic stenosis in patients who are non-surgical candi-
dates because of multiple comorbidities.
Methods Since the technique is performed using a
transvascular approach, pre-procedural assessment of the aor-
tic valve apparatus, ascending aorta and vascular access is of
paramount importance for both appropriate patient selection
and correct device selection. This assessment is performed by
a multi-disciplinary team with radiology being an integral and
important part.
Results Among imaging modalities, there is growing scientif-
ic evidence supporting the crucial role of MDCT in the as-
sessment of the aortic valve apparatus, suitability of the
iliofemoral or alternative pathway, and determination of ap-
propriate coaxial angles. MDCT also plays an important role
in post-procedure imaging in the assessment of valve integrity
and position.
Conclusion This review outlines the principal aspects of
TAVR, the multidisciplinary approach and utilisation of
different imaging modalities, as well as a step-by-step ap-
proach to MDCT acquisition protocols, reconstruction tech-
niques, pre-procedure measurements and post-procedure
assessment.
Teaching Points
• TAVR is a new technique to treat severe aortic stenosis in
high-risk and nonsurgical candidates.
• MDCT assessment of the aortic annulus is important for
appropriate patient and device selection.
• Multidisciplinary approach is required for patient selec-
tion, procedure planning and performance.
• MDCT is required for assessment of the aortic root,
iliofemoral or alternative vascular pathway.
Keywords TAVR .Aortic annulus . MDCT . ECG-gating .
Multiplanar reconstructions
Introduction
Aortic stenosis is the most common valvular disorder in
developed countries, affecting 2–5 % of the population over
75 years old [1, 2]. Once symptoms develop, the mortality
increases rapidly to approximately 50 % within 2 years [3, 4].
The standard of care in treatment of patients with symptomatic
severe aortic stenosis remains surgical aortic valve replace-
ment (sAVR), which has low peri-operative mortality and
improved clinical outcomes [5]. However, high-risk patients
often have significant comorbidities such as coronary heart
disease, renal insufficiency, lung disease, cerebrovascular dis-
ease or frailty that limit their chance of survival [6, 7]. The
most commonly used scoring tool to estimate 30-day mortal-
ity after cardiac surgery is the Society for Thoracic Surgery
Predicted Risk of Mortality score (STS PROM) [8]. For the
patient population considered unsuitable or at high-risk for
sAVR because of underlying comorbidities, the development
D. E. Litmanovich (*) :M. Shahrzad :A. A. Bankier
Department of Radiology, Beth Israel Deaconess Medical Center,
330 Brookline Ave-Shapiro 4, Boston, MA 02215, USA
e-mail: dlitmano@bidmc.harvard.edu
E. Ghersin
Department of Radiology, Leonard M. Miller School of Medicine,
University of Miami and Jackson Memorial Medical Center, 1611
NW 12AvenueWest Wing 279; LC: R-109,Miami, FL 33136, USA
D. A. Burke
Cardiovascular Institute, Beth Israel Deaconess Medical Center, 185
Pilgrim Road Palmer 4, Farr Building, Boston, MA 02215, USA
J. Popma
Department of Cardiology, Beth Israel Deaconess Medical Center,
330 Brookline Ave-Shapiro, Boston, MA 02215, USA
Insights Imaging (2014) 5:123–145
DOI 10.1007/s13244-013-0301-5
of transcatheter aortic valve replacement (TAVR) has
resulted in an alternative therapy for symptom relief and
extension of life [9].
Aortic valve apparatus anatomy
The aortic valve complex consists of the aortic valve annulus,
commissures, sinuses of Valsalva (SOV), coronary ostia (CO)
and sinotubular junction (STJ). Three aortic valve cusps are
connected proximally to the wall of the left ventricular out-
flow tract (LVOT) [10] by three anchor points at the nadir
(hinge point) of each aortic cusp. Those nadir points, when
virtually connected, form an oval-shaped, three-pronged cor-
onet—the “virtual basal ring” (Fig. 1). The orientation of this
virtual basal ring, or aortic annulus, is double oblique and does
not correspond to conventional axial, coronal or sagittal
planes ofMDCT. This ring is the major target for transcatheter
aortic valve prosthesis sizing.
Distally, the three semilunar leaflets are attached to the wall
of the aortic sinus at the surgical annulus that corresponds to
the sinotubular junction: the junction between the SOV and
ascending aorta. Multiple manipulations of the raw imaging
data are required to create an image that would exactly corre-
spond to the aortic annulus (virtual basal ring). This virtual
basal ring is often not orthogonal to the LVOT, and insertion
of the right coronary cusp can often be inferior to the left and
non-coronary cusps [11].
TAVR: review of the device and procedure
There are currently two transcatheter heart valves (THVs) avail-
able for use in the US: the Edwards SAPIEN valve (Fig. 2) and
a
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aortic valve complex is a
formation consisting of the aortic
valve annulus, commissures and
sinotubular junction (STJ). Three
aortic valve cusps are connected
proximally to the wall of the left
ventricular outflow tract (LVOT)
by three anchor points at the nadir
(hinge point) of each aortic cusp.
Those nadir points, when
virtually connected, form an oval-
shaped, three-pronged coronet—
the “virtual basal ring”
Fig. 2 a Balloon-expandable
Edwards SAPIEN transcatheter
heart valve with bovine
pericardial leaflets. The first
generation frame was made of
stainless steel and the newer
version Edwards SAPIEN XT
THVis made of cobalt chromium.
b The Edwards Sapien THV
crimped on delivery catheter
balloon. c Fully balloon
expanded THV. (Source:
Edwards Lifesciences)
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the Medtronic CoreValve prosthesis (CoreValve) (Fig. 3). Both
devices were granted Conformité Européenne (CE) approval in
Europe in 2007, and the Edwards SAPIEN valve was approved
for commercial use in the US in 2011 following the landmark
PARTNER trial [12, 13]. The CoreValve device is currently
available in research trials only. The main characteristics of both
devices are summarised in Tables 1 and 2, with some specific
features outlined below. Both devices are predominately
delivered through a transfemoral approach involving either
percutaneous or surgical cutdown for arterial access (Fig. 4).
The Edwards SAPIEN is a ballon-expandable stent. The
earlier generation valve is available in 23- and 26-mm valve
sizes and is delivered via a 22- or 24-French delivery system,
respectively. A newer version, the SAPIEN XT, is available in
23-, 26- and 29-mm sizes using a smaller transfemoral delivery
sheath system (18 and 19 French, which requires a minimal
iliofemoral luminal diameter of 6 mm). Due to its short stent
frame length, the Edwards SAPIEN valve can be deployed in
the aortic annulus without any significant limitations in terms of
sinus of Valsalva size, sinotubular junction or ascending aortic
diameter. The balloon-expandable frame assumes its shape with
a single inflation, and the aortic annulus typically conforms to
the shape of the device with a more circular geometry (Fig. 5).
Available in 23-, 26-, 29- and 31-mm sizes, the Medtronic
CoreValve device (Table 1) is a self-expanding prosthetic valve
requiring an 18-French delivery catheter (a minimal iliofemoral
luminal diameter of 6mm). The longer CoreValve device frame
requires sufficient ‘outflow’ room to be deployed but the device
is available in a wider range of sizes allowing patients with
particularly larger annular diameters to be treated. The radial
force of the self-expanding frame holds the device in position at
the level of the annulus. This same radial force is thought to
increase the need for a permanent pacemaker because of com-
pression on conduction tissues, an issue more prevalent with
the CoreValve device.
Depending on the specific device, there are several poten-
tial additional vascular access routes for implantation [14]:
Fig. 3 Medtronic CoreValve Transcatheter Heart Valve composed of a
self-expanding nitinol stent structure with porcine pericardial valve leaf-
lets. (Source: Medtronic)
Table 1 Comparison of
the Edwards SAPIEN XT and
Medtronic CoreValve Prostheses
a Edwards SAPIEN XT 29 mm
requires peripheral vessel patent
lumen diameter of >7 mm
Modified from [63]
Characteristics Edwards SAPIEN XT Medtronic CoreValve
Frame Cobalt chromium Nitinol
Leaflets Bovine pericardial Porcine pericardial
Expansion Balloon expandable Self-expanding
Repositionable No Yes
Retrievable No Yes
Annular/valvular fixation Yes Yes
Ascending aorta fixation No Yes
Sheath internal diameter 18-F, 19-F 18-F
Sheath external diameter 7 mm 7 mm
Minimal arterial diameter 6 mma 6 mm
Suitable for
Dilated ascending aorta Yes No
Transapical access Yes No
Transaxillary access Yes, limited experience Yes, limited experience
Transaortic access Yes Yes
Longest published follow-up >6 years >4 years
Pacemaker requirement 3 %–8 % 14 %–40 %
FDA approval SAPIEN transfemoral only No
Randomised trial results PARTNER A and B Results anticipated 2013
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(1) The transapical approach is the second most common
access route for TAVR using the Edwards SAPIEN valve
(Fig. 6). It essentially affords a direct path to the aortic
valve via surgical thoracotomy. While refinements in
apical-purse string suturing techniques have reduced
bleeding complications, this remains an invasive ap-
proach in elderly frail patients.
(2) The direct aortic approach was originally developed for
use with the CoreValve device as the larger stent frame
precluded the transapical route. Although this still re-
quires a partial sternotomy or right anterior thoracotomy,
this is arguably less invasive than the incision required
for the transapical route and is gaining favour (Fig. 7)
[15].

















Edwards SAPIEN XT 23 mm 18–22 ≥10 >6 14.3
Edwards SAPIEN XT 26 mm 21–25 ≥10 >6.5 17.2
Edwards SAPIEN XT 29 mm 24–27 ≥10 >7.0 19.1
Medtronic CoreValve 23 mm 18–20 ≤40 ≥15/≥27 >6 45
Medtronic CoreValve 26 mm 20–23 ≤40 ≥15/≥27 >6 53
Medtronic CoreValve 29 mm 23–27 ≤43 ≥15/≥29 >6 55
Medtronic CoreValve 31 mm 26–29 ≤43 ≥15/≥29 >6 52
THV transcatheter heart valves
Modified from [11] and [63]
Fig. 4 Transfemoral access
approach using the Edwards
SAPIEN transcatheter heart valve.
a THV crimped onto a balloon at
the tip of the delivery catheter
positioned across the native aortic
valve. b Expanded balloon with
THV deployed in position.
Angiographically the aim is for a
50:50 deployment with half of the
device above and half below the
annular plane. c The Edwards
SAPIEN transcatheter heart valve
in correct position in situ. (Source:
Edwards Lifesciences)
Fig. 5 Aortic annulus shape
before and after TAVR. Aortic
annulus has an oval shape with
maximum and minimum
diameters (a). The minimum
diameter usually corresponds to
the diameters measured with TTE
and TEE. This oval shape will
be transformed into a more
circular shape after TAVR is
performed (b)
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(3) The subclavian/axillary approach was originally de-
veloped for use with the CoreValve device; it can be
used for the Edwards SAPIEN prosthesis. With
CoreValve device this approach has been losing
ground to direct aortic access in recent years.
Disruption and dissection are more common with
catheter manipulation in the subclavian artery, and
caution is required in patients with previous coro-
nary artery bypass grafting in which the left internal
mammary artery was used [16, 17]. There are re-
ports describing brachiocephalic access as an alternative
approach [18].
TAVR is performed with cardiac surgery back-up and
typically general anaesthesia is used. Imaging during the
procedure is crucial for accurate device positioning, assessing
prosthetic valve function and efficient detection of procedural
complications. Positioning of the prosthetic valve is aided by
pre-determination of the annular plane orientation using pre-
procedure MDCT and rotational angiography with fluorosco-
py during the procedure (Fig. 8). Transesophageal echocardi-
ography (TEE) plays an important role in device positioning,
final placement and determiningTransoesophageal degree of
aortic regurgitation following deployment (Fig. 9). Main pro-
cedure risks and complications include vascular access com-
plications, aortic valve regurgitation, transvalvular and
paravalvular, stroke, conduction system abnormalities, pros-
thesis embolisation, mitral valve disruption, haemorrhage,
peripheral vascular complications and death [19, 20].
Patient selection for TAVR suitability
Currently TAVR is reserved for patients with symptomatic
severe aortic stenosis in whom pre-existing comorbidities
increase the risk of sternotomy and standard valve replace-
ment, and who are considered high or very high surgical risk
(Table 3). Aortic annular size appropriate for any of the
Fig. 6 Transapical access using
the Edwards SAPIEN THV. a
Delivery device in situ with
crimped device on balloon across
the native aortic valve. a Left
thoractomy is used to gain access
to the left ventricular apex and the
delivery catheter is advanced with
a purse-string suture technique for
haemostasis. b Expanded balloon
with deployed aortic valve
prosthesis in correct position.
(Source: Edwards Lifesciences)
Fig. 7 Direct aortic access approach using the Medtronic CoreValve
Transcatheter Heart Valve. a Arterial puncture and cannulation 7.5–
8.0 cm above the level of the aortic annular plane from the right side
via a mini-sternotomy. Shownwith stiff wire across the native aortic valve
and positioned in the left ventricular cavity. b Large-bore arterial access
sheath in situ with THV delivery catheter crossing the native aortic valve.
c Partially flared Medtronic CoreValve THV within the native aortic
valve. (Source: Medtronic)
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existing THV devices is an important inclusion criterion.
Multiple objective estimates of surgical mortality are applied
in the selection process of patients referred for TAVR [21–23].
A logistic EuroSCORE (European System of Cardiac
Operative Risk Evaluation) of 20 points or a Society of
Thoracic Surgeons Score of 10 points is often used as a risk
threshold to aid in decisionmaking [23]. As of 2013, there had
been more than 40,000 transcatheter valvular replacements
performed worldwide and approximately 7,000 cases per-
formed in the US.
Annular size not corresponding to any of the available
THV devices would be a major exclusion criterion, followed
by the lack of an appropriate vascular access route; for the
CoreValve device, this criterion would be sinus of Valsalva
dimensions too small or too large to accommodate the upper





the CoreValve THV in situ. a
Long-axis view showing heavily
stenosed aortic valve. b Short-
axis imaging showing a calcified
and stenosed aortic valve in
systole with poor leaflet opening
and small aortic valve opening
area. c Transesophageal long-axis
view showing the CoreValve
THV frame with the inflow
portion positioned in the left
ventricular outflow tract/aortic
annulus and the outflow (wider
frame) within the aortic root/
proximal ascending aorta. d
Transesophageal short-axis view
showing inflow of the device
frame in position within the left
ventricular outflow tract
Fig. 8 Intraprocedural fluoroscopy. Procedural fluoroscopy demonstrating
a pigtail catheter in the non-coronary cusp of the aortic root, with aortog-
raphy demonstrating the sinus of Valsalva and ascending aorta. The pigtail
catheter is used for intermittent aortography during the procedure to aid in
correct device positioning and also to determineTransoesophageal
haemodynamics and degree of aortic incompetence. a Baseline
aortography during a direct aortic access procedure (incision ‘spreaders’
shown). Aortography aids in identification of the optimal position for aortic
puncture needed to introduce the large-bore arterial access sheath. b
Baseline aortography with Swan-Ganz catheter in situ in the pulmonary
artery from right internal jugular access and transesophageal echocardiog-
raphy probe
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Pre-TAVR assessment of aortic root anatomy
with echocardiography and MDCT
Two- and three-dimensional transthoracic (TTE), transesoph-
ageal echocardiography (TEE), ECG-gated MDCTand rarely
cardiac magnetic imaging (CMR) (Figs. 10 and 11) can be
used for aortic valve apparatus assessment, with each imaging
technique providing complementary information for optimal
valve prosthesis sizing and THV selection. TTE, TEE and
MDCT are currently the primary modalities for aortic root
anatomy assessment.
Echocardiography assessment
Echocardiography is used to confirm severe aortic stenosis
(aortic valve area of <0.8 cm2, peak velocity across valve
>4 m/s and mean gradient >40 mmHg). It is also used to
assess the degree of aortic incompetence and other valvular
diseases, left ventricular systolic ejection fraction and diastolic
dysfunction, as well as to estimate right-sided and pulmonary
pressures. For TTE, the para-sternal long-axis view is used,
and for TEE, the mid-esophageal long-axis view is used. The
annulus is measured during early systole, with the valve
leaflets open, from the hinge point of the right coronary leaflet
to the hinge point of the non-coronary leaflet. THree-
dimensional TEE may provide more accurate assessments of
the aortic annulus compared to 2D-TEE, which may impact
prosthesis size selection, although more research in this area is
needed [24, 25]. Despite promising results and crucial infor-
mation, 3D TEE is not yet a standard practice in pre-TAVR
aortic annulus measurement assessment. TEE allows for real-
time imaging during the TAVR procedure while assisting in
device placement and positioning as well as assessing the
degree of aortic regurgitation [12]. Other complications such
as pericardial tamponade, severe mitral regurgitation, aortic
dissection, LV damage and embolisation of the implanted
valve can also be diagnosed intra-procedurally with TEE.
[12].
MDCT assessment
The Society of Cardiac Computed Tomography (SCCT) ex-
pert consensus document on MDCT imaging before TAVR
suggests using at least a 64-detector scanner, with an obvious
advantage of 128, 256 and 320 slice scanners with their
shortened acquisition time and decreased contrast volume
[11, 26] and high-pitch spiral dual-source CT angiography
protocol [27]. Imaging should be performed in the supine
position and during suspended respiration [11]. Since preci-
sion in the range of 1 mm is desirable, spatial resolution must
be high with an acquisition protocol that obtains a reconstruct-
ed slice width of ≤1.0 mm throughout the entire imaging
volume, particularly of the aortic valve, aortic root and ilio-
femoral arteries.
Fig. 10 An 81-year-old male following TAVR with a 31-mm Medtronic
CoreValve*. Coronal oblique MPR of an enhanced MDCT before TAVR
(a) and coronal oblique thick MPR of a non-enhanced MDCT following
TAVR (b). Key anatomic landmarks: Native aortic valve annulus plane
(solid black arrow), left main coronary artery emanating from the left
coronary sinus of Valsalva (dotted black arrow), sinotubular junction
(dotted white arrow), ascending aorta approximately 4 cm above the native
aortic valve annulus plane (solid white arrow); Medtronic CoreValve
(double-headed arrows) and mitral valve annular calcifications (*). Note
normal positioning of the Medtronic CoreValve with the upper portion at
ascending aorta (double-headed white solid arrow), mid portion at the
sinuses of Valsalva (double-headed dotted white arrow) and lower portion,
“inflow” aspect at or just below the native aortic valve annulus plane
(double-headed solid black arrow)
Table 3 Inclusion and exclusion criteria for TAVR
Inclusion criteria:
Critical aortic stenosis (with mean aortic valve area of <0.8 cm2)
Multiple comorbidities with 1-year mortality rate exceeding 20 %
Poor outcome with medical management
Non-surgical candidates with TAVR representing the only suitable
alternative
Native aortic annular size appropriate for currently available THV
size criteria
Exclusion criteria: unsuitable native anatomy
Lack of appropriate access to implant the device
Sinuses of Valsalva unable to accommodate prosthetic valve
Native aortic annular size inappropriate for currently available THV
size criteria
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Aortic annulus apparatus imaging
For precise aortic valve annular sizing and root evaluation,
ECG-gated CT angiograms of the ascending aorta and heart
are obtained with either prospective or retrospective ECG
triggering. Aortic valve and root assessment during systole
has been shown to be preferable to during diastole because of
the larger annular size noted in systole as well as dynamic
changes [28, 29]. Thus, with both prospective and retrospec-
tive gating, the data should be acquired during systole (usually
20–50 % phase of the cardiac cycle) with no radiation during
the rest of the cycle in prospective ECG triggering and very
aggressive dose modulation with retrospective gating,
allowing substantial dose savings. No routine administration
of β-blockers is used for scanning purposes because of con-
cerns with underlying severe aortic stenosis. A high incidence
of arrhythmia in TAVR candidates precludes routine use of
prospective gating on a routine basis. As a result, the estimated
radiation dose may be relatively high, but acceptable given the
advanced age of the vast majority of TAVR candidates and the
amount of information acquired. For younger patients, with
stable and low heart rates, prospective axial acquisition during
the systolic phase is suggested [26]. Tube potential of 100 kV
is suggested for patients weighing less than 90 kg or with a
body mass index (BMI) less than 30, whereas a tube potential
of 120 kV is usually indicated for patients weighing more than
90 kg (BMI >30). The lowest setting possible should be
selected in keeping with acceptable image noise [30].
Image acquisition triggering can be obtained automatical-
ly or by using a bolus injection technique for determining the
transit time. The region of interest (ROI) can be placed on the
proximal descending aorta using a pre-selected HU threshold.
Arterial enhancement in studies performed with a 64-slice
scanner demonstrates more consistency with the bolus injec-
tion technique, but requires higher contrast volume (typically
an additional 20 ml of contrast medium). The vast majority of
medical centres imaging TAVR candidates follow one of the
two two-step protocols (Table 4). Reduction of contrast vol-
ume can be achieved by using lower flow rates such as 3 ml/s
or less [31]. Dual-energy techniques allow adequate enhance-
ment with lower intravenous contrast volumes [32]. In ex-
treme cases of renal insufficiency, direct aortic injection
with extremely low volumes of contrast (,20 ml) can be
used [33, 34].
Image reconstruction of the aortic valve apparatus requires
a complex reconstruction technique based purely on aortic
valve anatomy. No single image reconstruction protocol ex-
ists, but similarities between clinical centres and approaches
exist. Currently the most widely used method for reconstruc-
tion of aortic valve annulus is based on sequential double-
oblique reconstructions that ultimately provide the image
corresponding to the aortic valve annulus. The post-
processing approach used for assessment of the aortic root
and ascending aorta has been described in detail by
Achenbach et al. and Leipsic et al. (Fig. 12) [11, 26]. As with
all other types of CT post-processing, the quality and precision
of reconstructed images depend on the quality of the raw CT
Table 4 Suggested IV contrast injection regiments
64-Detector scanner 320-Detector scanner
Gated cardiac CTA Gated CTA chest
Bolus injection, 20 ml IV contrast Automatic triggering
ROI: proximal descending aorta ROI: proximal descending aorta
Peak enhancement selected Threshold of +200 HU used
Main injection: 4 ml/s, 70–80 ml Rate: 4 ml/s, 120–140 ml
Non-gated CTA abdomen, pelvis Non-gated CTA abdomen, pelvis
Additional 50 ml is injected Done immediately after chest CTA
Injection timing based on
bolus results
No additional IV contrast required
Total: Total:
130–150 ml 120–140 ml
ROI Region of interest
Fig. 11 A 66-year-old male with aortic stenosis. a Steady-state free
precession MR image at peak systole in coronal plane shows hypointense
jets in the aortic root (white arrows), which result from dephasing of
turbulently flowing blood, consistent with haemodynamically significant
aortic valve stenosis. b Steady-state free precession MR image at peak
systole in short axis plane of aortic valve shows a tricuspid aortic valve
with valve leaflet thickening because of sclerosis and/or calcifications
(white arrows). c Planimetry in the short axis plane of the aortic valve at
peak shows maximal valve opening of 0.86 cm², consistent with severe
aortic valve stenosis. MR imaging is particularly useful for TAVR candi-
dates with renal failure since necessary measurements can be obtained
without administration of gadolinium
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Fig. 12 Sequence of images
describing the step-by-step
process of creating a plane that
precisely corresponds to the aortic
annulus [17, 24]. a Thin-sliced
axial reconstructions (0.625 mm
for GE and 0.5 mm for Toshiba)
are used to create standard
coronal, sagittal and transverse
plane reconstructions. b Coronal
plane reference line is rotated to
bring the former axial plane as
close as possible to the plane of
the valve. c The reference line in
the coronal image that controls
the former axial plane is moved
up and down to identify the
lowest insertion point of the right
coronary cusp, and the former
axial plane is positioned exactly at
the level of the right cusp
insertion point. d The reference
line in the formerly axial plane is
rotated such that the line that
controls the former sagittal plane
crosses the lowest insertion point
of the non-coronary cusp (located
approximately at the 8 o’clock
position, *). e Manipulation with
the former sagittal plane,
currently showing the lowest
insertion of the right and non-
coronary cusp. On this plane, the
reference line of the former axial
plane should be rotated until it
crosses the two insertion points. f
On the former coronal plane the
reference line of the former axial
plane is rotated until the lowest
point of the left coronary cusp
appears on the formerly axial
plane window. At this point the
formerly axial plane is now
rotated to represent the correct
orientation and level of the aortic
valvular plane. This image should
be used to provide all the precise
pertinent measurements
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data. The presence of a high heart rate, arrhythmia and severe
valve calcifications can substantially degrade image quality
(Fig. 13). If these limitations present, they should be addressed
in the report, and a decision should be made on the necessity
of repeated imaging or acquiring the data with alternative
imaging modalities.
Measurements of the aortic valve as well as qualitative
assessment should be done based on properly reconstructed
images (see above). Three main measurements have been sug-
gested as beingmost informative regarding aortic annular sizing
and THV selection (Table 5) (Fig. 14): (1) Aortic annulus
diameters: long and short diameters are measured, and the mean
diameter is calculated by averaging short and long diameters
[35]. (2) The circumference (perimeter) of the aortic annulus can
be either calculated under the assumption that the area corre-
sponds to full circularity or measured manually (Fig. 15). (3)
Aortic annulus area can be calculated based on the mean diam-
eter or measured manually using the planimetry technique.
Aortic annulus dimensions should be measured in systole,
similar to echocardiography, since both the area and mean
diameters are larger in systole [36]. No substantial difference
in circumference was found across the cardiac cycle [26, 37].
Additional aortic valve apparatus measurements pertinent
for TAVR dimensions include the aortic valve cusps, aortic
valve commissures, sinuses of Valsalva, coronary ostia and
sinotubular junction. The parameters important for pre-TAVR
assessment are summarised in Table 6. The most important
factors are discussed below.
Aortic valve calcifications (AVCs) are either diffusely or
focally located on the aortic surface of thickened aortic valve
cusps. If excessive, these calcifications may prevent appropriate
alignment of the prosthesis, leading to gaps between the pros-
thetic valve and the aortic annulus and subsequent paravalvular
aortic regurgitation (leak), as well as increased risk of annular
rupture, device dislodgement or obstruction of coronary ostia
due to opposition of calcified aortic cusp [34, 38–42] (Fig. 16).
Calcification of the aortomitral continuity may increase the risk
of annular rupture with balloon dilatation (Fig. 17). AVC can be
assessed in the cross-sectional view of the sinus of Valsalva
(SOV) either qualitatively (mild, moderate, severe) or quantita-
tively using Agatston units (Agatston Score), the calcified vol-
ume score (in mm3) or mass score (in mg of CAHA), similar to
the assessment of coronary calcifications [38, 43]. Agatston
scores exceeding 3,000 are correlated with an increased inci-
dence of paravalvular regurgitation after TAVR [44].
Semiquantitative scores assess the number of affected cusps,
homogeneous versus more focal distribution of calcium and
involvement of coronary versus non-coronary cusps. Calcium
burden is quantified at the aortic annulus and at the SOVat both
its inferior portion and superior aspect. Post-deployment
balloon dilatation is required more frequently in patients
with severe valvular calcification [45].
Perpendicular Plane(MPR) Perpendicular Plane(MPR)a b
Fig. 13 Suboptimal imaging of the aortic annulus in a patient with
irregular high heart rate. An 85-year-old female with rapid atrial
fibrillation. Due to the irregular heart rate, substantial image reg-
istration artefacts severely degraded image quality of CT raw data
as well as subsequent post-processing images. Thus, all the re-
quired measurements—(a ) aortic annulus and (b ) width of the
SOV, cannot be reliably assessed
Table 5 Aortic valve apparatus/ascending aorta measurements pertinent
for TAVR
Aortic annulus (AA) (virtual basal ring)
• AA maximal diameter
• AA perpendicular minimal diameter
• AA average diameter





• Aortic annulus calcifications
• Severely calcified cusp that might compromise coronary the
artery ostia: yes/no
Ascending aorta
• Width at 40 mm from the annulus




• Sinotubular junction maximum diameter
• Distance from the aortic annular plane to the coronary artery ostia
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Distance of the coronary ostia to the aortic annulus plane:
Coronary arteries generally arise within the SOV, below the
level of the sinotubular junction (STJ). The right coronary artery
generally lies higher than the left coronary artery, with average
distance between the plane of the aortic annulus and coronary
artery ostium (CAO) of 15.5 mm on the left and 17.3 mm on the
right [46]. Degenerative aortic stenosis may result in longitudi-
nal remodeling of the SOV with decreased distance from the
aortic valve annulus to the CAO (Fig. 18). The combination of a
relatively low-lying coronary artery ostium and a large native
aortic valve leaflet can therefore obstruct the flow into the
coronary arteries during device deployment. The height of the
CAO is determined by identifying the origin of the coronary
artery from the cross-section MPR and then measuring the
vertical distance between the inferior edge of the CAO and the
aortic annular plane. If coronary ostia height is more than 10–
14 mm in patients with planned THV implantation, the chance
of obstruction is low [11].
The width and maximal height of the SOV are important
parameters for coronary perfusion with THV, determining
whether the THV will be accommodated within the SOV
without causing coronary occlusion from displacement of
the native aortic valve leaflets [47] (Fig. 19). As for the rest
of the aortic valve apparatus, measurements of the aortic sinus
a b
c d
Fig. 14 Assessment of aortic
annular plane. a Aortoventricular
centreline is created manually. b
Based on a centreline, double-
oblique MPR images are created
at the pre-selected level of the
basal annular plane (AA) with all
the AAmeasurements obtained at
this level. c The 3D volume-
rendering reformats of the
aortovalvular complex are
generated based on the same
centreline. d Manual
measurements of maximum and
minimum aortic annulus diameter
and perimeter
Fig. 15 Examples of different
sizes of aortic annulus
corresponding to different sizes of
Medtronic CoreValve prostheses.
The measurements of the aortic
annulus shown above would be
appropriate for (a) Medtronic
CoreValve 23 mm, (b) Medtronic
CoreValve 31 mm
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diameter and height should be assessed on a double-oblique
projection. The SOV width assessment is particularly impor-
tant for the CoreValve device with a minimum 27 mm re-
quired for the 26-mm prosthesis and 29 mm for the 29- and
31-mm prostheses; the minimum SOV height is 15 mm
(Table 6) [26].
The diameter of the ascending aorta: For CoreValue de-
vices, orientation of the direction of the device flow occurs
when the frame contacts the inner and outer curvature of the
aorta. Ascending aortic dilatation of more than 43 mm (when
measured 4 cm above the basal aortic annulus plane) pre-
cludes the use of the 29- and 31-mm CoreValve device.
Dilatation of more than 40 mm precludes the use of the 23-
Table 6 Crucial factors for assessing the aortic and peripheral vascular
access
Minimal patent arterial luminal short axis diameters
• Aorta
• Common iliac arteries
• External iliac arteries




• Mild, moderate, severe













Fig. 16 Quantitative volumetric assessment of the native aortic valve
apparatus calcification burden based on pre-TAVR ECG-gated cardiac
MDCT. This technique requires creation of a series of 3-mm-thick con-
tiguous double-oblique CT images in the short-axis plane of the native
aortic valve apparatus that will include the whole volume of the TAVR
device landing zone, defined as the area of the aortic valve annulus,
valvular cusps and LVOT (up to the junction point of the anterior mitral
leaflet) (a). At each reformatted image using the planimetry technique,
regions of interest (ROI) are drawn around all perceived areas of calcifi-
cation (b). Note that the mean density of all drawn ROIs is significantly
higher by more than 2 SD than the mean blood pool density as measured
in (a), indicating true calcifications. These regions of interest at all levels
are added together and multiplied by the slice thickness (3 mm) to derive
a quantitative total volumetric calcium score in mm3 representing the
calcification burden of the entire native aortic valve apparatus
Fig. 17 Aortomitral continuity calcification. Calcification of the
aortomitral continuity (purple asterisk) that extends to the mitral valve
may also increase the risk of annular rupture with post-deployment
balloon dilatation, as demonstrated on this double-oblique reconstruction
of the aortic annulus
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and 26-mm CoreValve device. Size is of less concern for
valves that are short in length and confined to the aortic
annulus and sinus of Valsalva such as the Edwards SAPIEN
valve [11].
Additional features that might interfere with successful
implantation: The left ventricular outflow tract (LVOT) is
the area between the basal annulus and the anatomic
aortoventricular junction. The atrioventricular (AV) node is
located adjacent to the membranous septum of the LVOT
below the aortic valve. Deep positioning of the THV into the
LVOT may cause injury to the interventricular septal and
artrioventricular conduction system. The degree of LV upper
septal hypertrophy protruding into the LVOT can hinder ac-
curate placement of the valve and present a significant risk of
THV repositioning. The aortoventricular angle is the angle
between the proximal aorta, aortic annulus and LVOT
(Fig. 20). This angle is determined by the angle of the hori-
zontal plane and the angle of the aortic annulus [26]. The
aortoventricular angle is an important consideration when
using THVs that are long in length and require deployment
perpendicular to the native annular plane. Each type of THV
has a maximum aortoventricular angle for successful valve
deployment, typically 70º for the iliofemoral approach and 30º
for the subclavian approach, due to angulation from the right
subclavian into the ascending aorta.
Peripheral vascular pathway, aorta, chest wall and left
heart imaging
Imaging of peripheral access can be obtained with non-gated
spiral acquisition to minimise radiation. Peripheral access
includes the iliofemoral, transsubclavian, transapical and di-
rect aortic access routes. Transapical and direct aortic access
(ascending aorta) routes are assessed with the ECG-gated
portion of the MDCT. The common femoral artery should
be included in the field of view when assessing femoral
access. Assessment of the axillary and subclavian arteries
should be obtained with the patient’s arms placed along his/
her body to exclude pseudo narrowing of the imaged
vasculature.
MDCT findings crucial in the peripheral vascular pathway
assessment are summarised in Tables 1, 2 and 6. MDCT
selection of patients with appropriate peripheral access has
 .
 RCA – right coronary artery,             
LMCA – left main coronary artery,  
                                                           
SOV – sinuses of Valsalva,  
                                                           





Fig. 18 Distance of the coronary
ostia to the aortic valve plane–
coronary artery height. The height
of the right coronary ostium is
determined by identifying the
origin of the RCA from the
transverse MPR parallel to the
aortic annulus plane (a) and then
measuring the height of the
coronary artery above the basal
annular plane (b). In a similar
fashion, the origin of the LMCA
is identified from the transverse
MPR (c) and then measuring the
height of the LMCA above the
basal annular plane (d). In this
case, the LMCA origin is above
that of the RCA. (e) Relationship
between the height of the LMCA
origin and the maximum width of
the SOVand aortic annulus plane
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substantially reduced the risk of vascular complications from
30.1 % [12] to 8 % [48]. A sheath-to-femoral artery ratio
≥1.05 has been shown to be associatedwith increased vascular
complications and 30-day mortality [36, 48]. A standardised
approach for peripheral access has been developed, adding
significant reduction in vascular injury rates [48]. Accepted
practice is to evaluate peripheral access with several recon-
struction techniques: curved multiplanar reconstructions
(MPR), 3D volume-rendered images and, if necessary, maxi-
mum intensity projection (MIP) images (Fig. 21). These mul-
tiple measurements are taken along the common iliac, external
iliac, common femoral, innominate, subclavian and proximal
axillary arteries bilaterally.
Vessel tortuosity in the iliofemoral or brachiocephalic/
subclavian arteries can be optimally assessed using 3D recon-
structions, with multiple oblique views seen along the 360°
circle in addition to the anterior-posterior view. Precise angle
measurements are obtained using PACS or workstation angle
measurement tools. Note that vessel angulation of 90° or more
may be a contraindication for large-bore catheter insertion
(Fig. 22). The burden and pattern of vascular calcifications
and presence of circumferential or horseshoe calcification can
be better assessed on curved multiplanar and maximum inten-
sity projection (MIP) reconstructions. The combination of
relatively small vessel caliber or stenotic segments with these
types of vascular calcifications is a relative contraindication
Fig. 19 Measurements of sinus
of Valsalva height, width and
perimeter. The widths (a , red
line) and maximal height (a ,
yellow arrow) of the SOVare
important parameters for
coronary perfusion after TAVR as
they determine whether the
valvular prosthesis will be
accommodated within the SOV
without causing coronary
occlusion from displacement of
the native valve leaflets. First, to
measure the SOV parameters, 3D
volume-rendering reconstruction
is created, with the area of
interested selected at the
maximum diameter of SOV (b ,
green line). Then, based on
curved multiplanar reconstruction
(c), a true perpendicular image is
created (d) where the maximum
diameter is measured. The
perimeter of the SOV can also be
assessed on the same image (e)
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for a transfemoral approach. However, a relatively straight
segment with no substantial calcification or atheroma can be
cannulated even if marginally smaller in diameter than the
intended sheath [49]. The presence of dissection or a complex
atheroma is assessed on both axial and curved reconstruction
images, with such findings again considered contraindications
for a transfemoral approach. If the iliofemoral approach is not
an option for a given patient, transapical, direct aortic, direct
brachiocephalic or subclavian artery approaches should be
assessed (Figs. 23 and 24).
For all TAVR approaches, assessment of the entire aorta is
done routinely as part of the pre-procedure protocol using
curved MPR with subsequent creation of true perpendicular
axial images for precise patent lumen diameter assessment.
For the transfemoral approach, the aorta is assessed to exclude
the presence of an abdominal aneurysm, elongation with
Fig. 20 A-E Aortoventricular
angle assessment. a The
aortoventricular angle is best
determined from the coronal view
by determining the angle of the
horizontal plane (blue) at the level
of the ventricle and aortic annulus
angulation (red). Green: aortic
longitudinal access. b The
aortoventricular angle is
determined by the angle of the
horizontal plane and the angle of
the aortic annulus. In this case, the
aortoventricular angle is 41º. (c,
d) The AVangle can also be
established during angiography,
although it may be time
consuming and disruptive during
the actual procedure. e The angle
can also be seen after deployment
of the TAVR catheter (this patient
had remote replacement of the
mitral valve)
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kinking of the aorta, dissection or large thrombi protruding
into the lumen and/or complex atheromas, as these are con-
traindications for transfemoral approach [11]. For the direct
aortic approach, assessment of the ascending aorta for the
presence and pattern of calcification is of paramount impor-
tance, as calcium may interfere with direct puncture of the
aorta. In these cases, the ascending aorta from the aortic
annulus plane to the origin of the brachiocephalic artery is
assessed for the presence of aneurysmatic dilatation or
circumferential/anterior calcifications (Fig. 25). The relation-
ship between the aorta and chest is important for planning
thoracic chest wall incisions. It is important to assess the
retrosternal area for the presence of masses particularly in
post-CABG patients to avoid bypass graft injury. After medi-
an sternotomy or a right parasternal incision has been per-
formed for the direct aortic approach, the aorta is punctured
either through its anterior or right lateral aspects (accordingly),
usually within the most proximal 8.5 cm, to allow sufficient
room for CoreValve device expansion.MDCT reconstructions
routinely include 3D VR reconstructions with osseous struc-
tures providing anatomic landmarks for future thoracotomy.
For transapical access , assessment of the entire aorta is less
crucial, unless a change in the approach is anticipated during
the procedure. The crucial data are the position of the left
ventricle (LV) apex relative to the chest wall and alignment of
the LV axis with the LV outflow tract. Also, left atrial (LA)
and/or LV thrombi can be a source of embolic complications
that will need to be identified and reported. As with the direct
aortic approach, chest deformities and mediastinal lesions are
important and should be reported and reviewed with the team
prior to the procedure.
Comparative analysis of echocardiography vs. MDCT
for aortic valve apparatus assessment
Historically, patient eligibility for transcatheter valve
therapy and sizing of the prosthesis were largely based
upon aortic annulus measurements on 2D echocardiogra-
phy (transthoracic or transesophageal) and occasionally
on angiography. The major disadvantage of these tech-
niques [50–52] is the underestimation of the oval and not
circular shape of the aortic annulus (Figs. 26 and 27)
[20]. Direct comparison of TEE and MDCT aortic annu-
lus measurements is problematic because of different
parameter measures by each of the modalities. Aortic
Fig. 21 Standard reconstructions for assessment of peripheral vascular
pathway. The approach includes first creation of a curved reformat of
each artery, including the aorta (a), as well as 3D volume-rendered
images (b). Those reconstructions provide landmarks to display the sites
of subsequent measurements of luminal diameter and 3D volume-render-
ing maximum intensity projection (MIP) reformats (c) demonstrate the
severity of aortic and ileo-femoral calcifications. Curved multiplanar
reformats, obtained with a centreline approach, serve as the source for
multiple luminal measurements made in a plane orthogonal to the vessel.
d, e, f show the process of assessing orthogonal axial planes with
measurements of the smallest diameters at each vessel level [common
iliac artery (d), external iliac artery (e), common femoral artery (f)]
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annulus diameter on coronal view by MDCT has been
shown to be significantly larger than that obtained on
sagittal view by MDCT, TTE or TEE [53]. Long-axis
measurement of the aortic annulus by TTE and TEE
approximates the minor axis of the elliptically shaped
annulus as measured by MDCT (Fig. 28). Thus, consis-
tently larger measurements obtained with MDCT as com-
pared with 2D echocardiography most likely reflect the
measurements of the largest of the two diameters of this
oval-shaped annulus as opposed to the smaller one mea-
sured by echocardiography [54–56]. The 2D echocardi-
ography usually underestimates the aortic annulus
average diameter by 1±1.7 mm [26, 52]. As a result of
the eccentric geometry of the oval aortic annulus, correl-
ative studies have shown a systematic underestimation of
annular sizing by 2D echocardiography alone [57].
MDCT can provide better estimates of both the long- and
short-axis diameter of the aortic annulus, surface area and
perimeter measurements. Extensive work has been done to
establish the role of MDCT in aortic annular sizing with
Edward Sapiens transcatheter heart valves (THV) [11, 26,
46]. While exaggerated oversizing of the THVand excessive
calcification of the native aortic valve can result in aortic
annular rupture, some THV oversizing is required for both
Fig. 22 Iliac artery angulation;
3D volume-rendered images of
the aorta, subclavian and iliac
vessels with skeletal landmarks.
Reconstruction provides
landmarks to display the sites of
subsequent measurements of
luminal diameter (a, b). The
degree of iliac artery angulation
can be measured easily on this
type of reconstruction (c)
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Fig. 23 a-f Assessment of
subclavian arteries. Assessment
of subclavian arteries is done in a
similar fashion to iliofemoral
assessment: centreline approach
to both the right (a) and left (b)
subclavian arteries serves as the
source for luminal measurements,
obtained with 3D VR (c), and
orthogonal to the vessel (d, e)
reconstructions with similar
parameters assessed, with 3D VR
(f) reconstructions used to assess
the tortuosity and plaque/
calcification burden
Fig. 24 Planning of the direct
aortic approach. Assessment of
entire ascending aorta is crucial to
exclude the presence of thoracic
aneurysm or anterior aortic wall
calcifications that might
potentially interfere with direct
puncture of the aorta. Typically,
the aorta is punctured within the
most proximal 8.5 cm. a The 3D
VR reconstructions of the
ascending aorta for assessment of
the diameter and presence of
anterior aortic wall calcifications.
Bone structures provide
landmarks for future thoracotomy.
Blue line, aortic valve plane; red
line, 8.5 cm above the plane of the
aortic valve, showing the area of
potential direct aortic access. b
Magnified view of 3D VR of the
ascending aorta with the 8.5-cm
landmark, (c) curvilinear
reconstruction of the ascending
aorta with (d) automatically
created perpendicular to (c) the
aortic plane with aortic diameter
measured at this level
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types of THV to prevent PAR. For the CoreValve device the
recommended device/annulus oversizing is 15 % of the aortic
basal ring perimeter. For the Edwards Sapiens valve, the
recommended device/annulus oversizing is 15–25 % of the
area and 7–12 % of the mean diameter. This degree of
oversizing of the THV appears to provide the best risk-
benefit ratio in terms of PAR reduction and conduction disor-
ders [57, 58]. Undersizing of the THV can lead to increased
PAR and greater likelihood of valve ‘pop-out’ or migration
[10, 59].
Fig. 25 A 76-year-old female
with severe aortic stenosis
assessed for potential
implantation of a Medtronic
CoreValve. Aortic diameter 4 cm
above the plane of the aortic
annulus is crucial: diameter
>4.3 cm may prevent even the
largest device from successfully
anchoring. The 3D volume-
rendered images provide
landmarks to display the sites of
subsequent measurements of the
ascending aortic luminal diameter
(a). This area is carefully
measured using a centreline
approach (b) with subsequent
luminal measurements made in a
plane orthogonal to the vessel (c)
Fig. 26 Aortic annular
measurement by (a) transthoracic
echocardiograpy: parasternal long-
axis view with measurement
shown. b Transesophageal
echocardiography (TEE): long-
axis view shown with annular
measurement. Transthoracic
echocardiography (TTE) typically
underestimates the aortic annulus
by approximately 1.0–1.5 mm
when compared to TEE or MDCT
Fig. 27 Correlation between
MDCT and TEE aortic basal ring
measurements. Elliptical shape of
the aortic annulus is appreciated
on MDCT reconstructions (a)
with the maximum diameter of
the valve corresponding to
coronal plane measurement
obtained by TEE (b). (Note that
in this figure the images belong to
two different patients)
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Post-implantation imaging
Post-implantation imaging can be divided into immediately
post-procedure and long-term follow-up. For the immediate
assessment of valve position and haemodynamic status, in-
cluding the gradients and effective valve area, the modality of
choice is TEE, which can be done in the hybrid procedure
room. Paravalvular and transvalvular regurgitation can also be
estimated in real time, allowing appropriate steps to be taken
to minimise complications and optimise device positioning
[16, 54].
For long-term follow-up of TAVR ECG-gated MDCT is
useful in diagnosing prosthesis misplacement by careful in-
spection of the exact positioning of the device in relation to the
aortic annulus plane [55].
Significantly low implantation may result in severe
paravalvular regurgitation, residual aortic valve stenosis, mi-
tral valve insufficiency, conduction abnormalities and, in ex-
treme cases, device drop into the left ventricular cavity.
Considerably high implantation may result in paravalvular
regurgitation, coronary flow obstruction and device emboli-
sation into the thoracic aorta [10, 60].
The exact definition of misplacement is specific to the
TAVR device type. The optimal deployment location of the
edge of the device, the inflow portion, should be positioned
approximately 4–6 mm below the aortic annulus plane [61,
62] (Fig. 29). The optimal deployment location of the
Edwards SAPIEN device is likely gained when 50 % of its
height is below and 50% of its height above the aortic annulus
plane [10, 60]. (Fig. 30).
Challenges and perspectives
TAVR is a novel procedure that provides unique opportunities
for multimodality research comparing different imaging strat-
egies and different THV devices. Given the exponential rise in
the number of procedures being performed with varying local
expertise, there is a need to standardise imaging protocols as
Fig. 28 Two types of protocols
used based on MDCT scanner
parameters: Two scout views
corresponding to a 64-slice
scanner (a) and 320- slice scanner
(b) demonstrate the approach to
data acquisition. First, the gated
(yellow rectangle) part of the
exam is obtained, including only
cardiac CTAwith the 64-slice
scanner and gated CTA of the
chest with the 320-slice scanner.
The second step (red rectangle)
corresponds to CTA chest,
abdomen and pelvis in the first
scenario (a) and CTabdomen and
pelvis in the second (b). Note that
in both cases eventually the entire
torso is imaged
Fig. 29 MDCT of the chest following the insertion of the Medtronic
CoreValve. The Medtronic CoreValve is normally positioned with its
upper portion at the ascending aorta (upper yellow arrow), mid portion
at the sinuses of Valsalva and lower portion, the “inflow” aspect, at or just
below the native aortic valve annulus plane (lower yellow arrow)
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Medtronic CoreValve® device requires that the most inferior
part of pre- and post-procedure assessment of TAVR patients.
Implementation of standardised protocols is crucial not only
for precise assessment of the aortic valve apparatus and vas-
cular access with different scanners in different institutions,
but also for creating opportunities for further multicentre
research. The SCCT expert consensus document devoted to
this topic suggests potential algorithms and techniques for
imaging before TAVR. Although there is growing evidence
of the importance of MDCT in the pre-procedure assessment,
one of the current challenges is to find the precise role of
MDCT in valve assessment and sizing. Thus, developing a
rational algorithm for imaging use both before and after im-
plant should become a priority to avoid substantial redundan-
cy in imaging. Another potential role for imaging is the
assessment of outcome prediction, based on the diagnosis of
both cardiac and non-cardiac comorbidities. If successful, this
should allow for optimised patient selection for the currently
costly procedure. Overall, current trends strongly suggest that
imaging, in particular MDCT, will play an increasingly im-
portant role in all aspects related to the TAVR procedure.
Summary
During the last decade transcatheter aortic valve replacement
has become widely used in many centres across the world
with good clinical outcomes. The planning and performance
of the procedure are based on a multidisciplinary team ap-
proach, with imaging proving crucial for pre-procedure plan-
ning. MDCT plays an important role in assessing the aortic
valve, aortic root and ascending aorta, as well as the access
root for the procedure (i.e., ilio-femoral, direct aortic or sub-
clavian) utilising the combination of multiplanar reconstruc-
tion and 3D imaging. TAVR technology and equipment are
rapidly advancing, with increased utilisation of advanced
MDCT imaging contributing to continuing outcome improve-
ment and broadening of procedure applications.
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